Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
27.05
+0.20 (0.74%)
Nov 24, 2025, 4:00 PM EST

Chugai Pharmaceutical Statistics

Total Valuation

CHGCY has a market cap or net worth of 87.88 billion. The enterprise value is 82.25 billion.

Market Cap87.88B
Enterprise Value 82.25B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date Jan 29, 2026
Ex-Dividend Date Dec 29, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.00%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 18.67%
Float 639.77M

Valuation Ratios

The trailing PE ratio is 32.74.

PE Ratio 32.74
Forward PE n/a
PS Ratio 10.72
PB Ratio 6.88
P/TBV Ratio 7.01
P/FCF Ratio 37.12
P/OCF Ratio 31.75
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.04, with an EV/FCF ratio of 34.74.

EV / Earnings 30.65
EV / Sales 10.62
EV / EBITDA 22.04
EV / EBIT 23.30
EV / FCF 34.74

Financial Position

The company has a current ratio of 5.68

Current Ratio 5.68
Quick Ratio 4.62
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 4,939.54

Financial Efficiency

Return on equity (ROE) is 21.52% and return on invested capital (ROIC) is 18.73%.

Return on Equity (ROE) 21.52%
Return on Assets (ROA) 16.26%
Return on Invested Capital (ROIC) 18.73%
Return on Capital Employed (ROCE) 28.87%
Revenue Per Employee 1.63M
Profits Per Employee 533,967
Employee Count5,026
Asset Turnover 0.57
Inventory Turnover 1.43

Taxes

In the past 12 months, CHGCY has paid 1.06 billion in taxes.

Income Tax 1.06B
Effective Tax Rate 28.23%

Stock Price Statistics

The stock price has increased by +31.10% in the last 52 weeks. The beta is 0.40, so CHGCY's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change +31.10%
50-Day Moving Average 23.61
200-Day Moving Average 24.23
Relative Strength Index (RSI) 65.28
Average Volume (20 Days) 141,417

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CHGCY had revenue of 8.20 billion and earned 2.68 billion in profits. Earnings per share was 1.63.

Revenue8.20B
Gross Profit 5.70B
Operating Income 3.74B
Pretax Income 3.74B
Net Income 2.68B
EBITDA 3.92B
EBIT 3.74B
Earnings Per Share (EPS) 1.63
Full Income Statement

Balance Sheet

The company has 5.96 billion in cash and n/a in debt, giving a net cash position of 5.96 billion.

Cash & Cash Equivalents 5.96B
Total Debt n/a
Net Cash 5.96B
Net Cash Per Share n/a
Equity (Book Value) 12.77B
Book Value Per Share 7.76
Working Capital 8.45B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.77 billion and capital expenditures -400.15 million, giving a free cash flow of 2.37 billion.

Operating Cash Flow 2.77B
Capital Expenditures -400.15M
Free Cash Flow 2.37B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 69.48%, with operating and profit margins of 45.58% and 32.72%.

Gross Margin 69.48%
Operating Margin 45.58%
Pretax Margin 45.60%
Profit Margin 32.72%
EBITDA Margin 47.75%
EBIT Margin 45.58%
FCF Margin 28.87%

Dividends & Yields

This stock pays an annual dividend of 125.86, which amounts to a dividend yield of 468.77%.

Dividend Per Share 125.86
Dividend Yield 468.77%
Dividend Growth (YoY) 20,295.27%
Years of Dividend Growth 1
Payout Ratio 75.49%
Buyback Yield -0.00%
Shareholder Yield 468.76%
Earnings Yield 3.05%
FCF Yield 2.69%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.

Last Split Date Jul 6, 2020
Split Type Forward
Split Ratio 12

Scores

CHGCY has an Altman Z-Score of 26.86 and a Piotroski F-Score of 4.

Altman Z-Score 26.86
Piotroski F-Score 4